GE-commissioned survey blasts neurological disease Dx delays

A survey commissioned by GE Healthcare ($GE) is critical of how patients with Alzheimer's, Parkinson's and multiple sclerosis are diagnosed. The conclusion: It took 7 to 12 months on average to form definitive diagnoses after the first onset of symptoms. Both physicians and patients took part in the survey. Physicians said about a third of patients could have been diagnosed sooner. The criticism is that delays in diagnosing the neurodegenerative conditions lead to either wrong or unnecessary treatments, creating added costs and anxiety. GE is developing imaging agents and other equipment focused, in part, on neurological disorders. Item